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Streszczenie
Przedstawiono opis przypadku 55-letniego mężczyzny cho-
rującego na rozlanego chłoniaka złośliwego typu B z towa-
rzyszącym przemijającym naciekiem skrzyżowania wzro-
kowego i zaburzeniami widzenia oraz przetrwałą niedo-
czynnością przysadki, hiperprolaktynemią i moczówką
prostą. Chorego leczono chemio- i radioterapią. Powtarza-
ne badania za pomocą jądrowego rezonansu magnetycz-
nego (NMR, nuclear magnetic resonance) i tomografii kom-
puterowej (TK) wykazywały naciek skrzyżowania nerwów
wzrokowych, który ustępował w wyniku chemioterapii
i znowu nawracał, zmieniał swój charakter i w końcu wy-
cofał się. Równocześnie pojawiły się zaburzenia widzenia,
które również ustąpiły w czasie leczenia. Stwierdzono wyma-
gające substytucji niedoczynność przysadki i moczówkę
prostą, a także hiperprolaktynemię. W późniejszym czasie
dołączyły się objawy brzuszne i w badaniu TK stwierdzono
obustronne zmiany w nerkach i powiększenie pozaotrzew-
nowych węzłów chłonnych. W badaniu histolopatologicznym
potwierdzono rozpoznanie rozlanego chłoniaka złośliwego
i miejscowe zapalenie węzłów chłonnych. Następnie wy-
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
kazano obecność płynu w jamie opłucnej i przestrzeni po-
zaotrzewnowej, a pacjent zmarł z powodu powikłań cho-
roby zasadniczej. W opisywanym przypadku udokumen-
towano długie przeżycie od czasu rozpoznania nacieku
okolicy podwzgórza i skrzyżowania wzrokowego w prze-
biegu chłoniaka, co jest rzadkością w chłoniakach ośrodko-
wego układu nerwowego. Z praktycznego punktu widze-
nia ważne są zaburzenia hormonalne towarzyszące nacie-
czeniu okolicy nadsiodłowej.
(Endokrynol Pol 2006; 6 (57): 642–647)
Słowa kluczowe: chłoniak, niedoczynność przysadki,
hiperprolaktynemia, moczówka prosta, zaburzenia widzenia
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Abstract
The case is reported of a 55-year-old man with diffuse mali-
gnant lymphoma type B associated with transient optic
chiasm infiltration and visual disturbances but with persi-
stent hypopituitarism, hyperprolactinaemia and diabetes
insipidus. The patient was administered chemotherapy and
radiotherapy. Repeated MR and CT scans showed optic
chiasm infiltration, which disappeared in the course of the
chemotherapy but then recurred, changed its appearance
and finally disappeared again. In the meantime visual di-
sturbances occurred and disappeared during the therapy.
Hypopituitarism, diabetes insipidus and hyperprolactina-
emia were diagnosed and replacement therapy was admi-
nistered. Later on abdominal pain occurred, and a CT scan
revealed bilateral kidney masses and enlarged retroperito-
neal lymph nodes. These were diffuse malignant lympho-
ma with regional lymphonodulitis in histology. Finally,
hydrothorax and hydroretroperitoneum were diagnosed.
The patient died as a result of systemic complications of the
disease. The length of survival time documented following
the hypothalamochiasmatic infiltration and diagnosis of
lymphoma makes the case an unusual one for patients with
CNS lymphoma. Hormonal disturbances accompanying the
suprasellar region infiltration are very important from the
practical point of view.
(Pol J Endocrinol 2006; 6 (57): 642–647)
Key words: lymphoma, hypopituitarism, hyperprolactinaemia,
diabetes insipidus, visual disturbances
Introduction
Malignant lymphoma is a generalised disorder with an
ability to involve various organs. Lymphoma or leuka-
emia of the central nervous system (CNS) is most fre-
quently meningeal and extradural, with intraparenchy-
mal deposit being extremely rare. Histologically, lym-
phomas of the CNS are almost always non-Hodgkin’s
lymphomas with a diffuse rather than a follicular pat-
tern, and the majority of them are B-cell tumours [1, 2].
Primary CNS lymphomas are not frequent and a pitu-
itary localisation may be followed by hypopituitarism
and other failures of the CNS. Several cases of primary
pituitary lymphoma have been reported to date [3–5].
Pituitary lymphoma can also be a part of widespread
systemic disease [6]. Optic chiasm infiltration by the
lymphoma leads to various forms of visual disturban-
ce. However, the reports of lymphomas located within
the optic chiasm are limited in number [7, 8]. Primary
hypothalamic lymphomas are quite unusual; they can
be followed by various symptoms including hypopitu-
itarism and diabetes insipidus. Hypothalamic lympho-
mas can mimic in their symptomatology the pituitary
ones, giving a clinical picture of pituitary hormone in-
sufficiency [9, 10].
We present a case of diffuse malignant lymphoma
associated with transient optic chiasm infiltration and
transient visual disturbances, but combined with persi-
stent hypopituitarism, hyperprolactinaemia and diabe-
tes insipidus.
Case report
The onset of the disease in a 55-year-old man was in
March 2001 with the enlargement of the left-side ingu-
inal lymph nodes. Histological evaluation revealed Lym-
phoma malignum lymphocyticum diffusum type B II A, [CD
20 (+), CD 45 RO (+), Bcl–2 (–), Ki-67 (–)]. Between
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March 2001 and November 2002 he was administered
seven cycles of COP (Cyclophosphamide, Vincristine,
Prednisone), which was followed by remission of the
disease. Some time later an enlargement of the ingu-
inal and parotic lymph nodes occurred again, and
a subsequent three cycles of chemotherapy, Cyclophos-
phamide, Vinblastine and Prednisone (CVP), were
necessary. Neither signs nor symptoms of hypopituita-
rism or diabetes insipidus were present at this time.
In August 2003 visual disturbances (bitemporal he-
mianopsia) occurred suddenly. The magnetic resonan-
ce (MR) scan performed shortly before their occurren-
ce (July 10th 2003) had already revealed optic chiasm
infiltration with third ventricle compression. The pitu-
itary gland was normal on the MR scan (Fig. 1a, b). Ra-
diotherapy was discussed, but finally four cycles of
CHOP (Cyclophosphamide, Epirubicine, Vincristine,
Prednisone) were administered. This treatment was tole-
rated very badly; it caused weakness, electrolyte distur-
bances, nausea, vomiting, polydipsia and polyuria. The
visual field defects disappeared gradually within this
period and a subsequent MRI scan (September 1st 2003)
showed complete regression of the lesion described pre-
viously (not shown). However, the signs and symptoms
mentioned above (diabetes insipidus) intensified and were
combined with those of hypopituitarism (weakness, hy-
potension, dry skin, constipation and impotence).
The computed tomography (CT) scan (November 6th 2003)
again showed a suprasellar hyperdense focus 1.8 cm in
size with contrast enhancement present (not shown). At
that time no peripheral, mediastinal or retroperitoneal
lymph nodes or neurological symptoms were observed.
There was only pleocytosis of 6 cells/ml in the cerebrospi-
nal fluid of 6 cells/ml, including 6 lymphoblasts. An addi-
tional intraspinal 12 cycles of chemotherapy (Cytarabine,
Methotrexate, Prednisone) were administered between
November 2003 and March 2004. The next MRI scan (No-
vember 28th 2003) confirmed the regression of infiltra-
tion (not shown), but the hormonal disturbances rema-
ined. The patient was then referred for positron emis-
sion tomography (PET) imaging of the whole body,
which revealed no expansive changes within the skull,
neck, chest, abdomen or pelvis (December 10th 2003, not
shown). Hormonal and biochemical analyses confirmed
secondary hypothyroidism, secondary adrenal insuffi-
ciency, hypogonadism, hyperprolactinaemia and central
diabetes insipidus. The hormonal data of the patient are
shown in Table I. Hormonal substitution was admini-
stered (L-Thyroxin, Hydrocortisone, Testosterone, Vaso-
pressin) with very good clinical effect.
A subsequent MRI scan showed a 6 mm hypointen-
sive lesion of the optic chiasm (March 17th 2004) (not
shown), which was interpreted as a recrudescence of
the disease, and radiotherapy using photons 6 MeV in
a total dose of 36 Gy/20 was administered.
Figure 1a. (MR 10.07.2003) Coronal contrast-enhanced T1-
-weighted MR image shows optic chiasm infiltration 1.7 × 1.3 cm
(arrow). Pituitary gland is normal
Rycina 1a. Obraz T1-zależny w projekcji czołowej wykonany po
dożylnym podaniu kontrastu wykazuje naciek skrzyżowania
wzrokowego o wymiarach: 1,7 × 1,3 cm (strzałka); przysadka
mózgowa jest prawidłowa
Figure 1b. (MR 10.07.2003) The same examination: sagittal
contrast-enhanced T1-weighted image; hyperintense mass in the
suprasellar region
Rycina 1b. To samo badanie — obraz T1-zależny w projekcji
strzałkowej po wzmocnieniu kontrastowym — w okolicy
nadsiodłowej jest widoczna hiperintensywna masa
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Complete remission of haematological disease con-
tinued until September 2004, and no chemotherapy was
necessary. The last MRI scan (August 18th 2004) showed
no pathological changes within the suprasellar region
(Fig 2a and 2b) and reflected a complete withdrawal of
the infiltration seen before.
In the meantime (October 2004) abdominal pain oc-
curred, and the CT scan revealed bilateral kidney mas-
ses (right: 5 × 3.5 cm, left: 2 × 1.5 cm in diameter, re-
spectively) and enlarged retroperitoneal lymph nodes
(3 cm). The patient underwent right nephrectomy and
left kidney tumour excision. There were diffuse mali-
gnant lymphomas with regional lymphonodulitis in
histology. Later the patient received Vepesid, DHAD,
Fludrarabine and Dexavene. In February 2005 hydro-
thorax and hydroretroperitoneum were diagnosed, and
DHAD was applied intrapleurally. CDA was then gi-
ven twice without success. From April 2005 the patient
did not continue follow-up and finally died in Septem-
ber 2005 as a result of systemic complications of the di-
sease. Until April 2005 the patient’s visual field and acu-
ity had shown no further impairment and he had recei-
ved continuous hormonal replacement.
Our patient, showing signs of transitory visual defi-
cits and permanent hypopituitarism, diabetes insipidus
and mild hyperprolactinaemia, is not typical, since his
pituitary was intact in all MR or CT images, and the
hypopituitarism observed was secondary to the
Figure 2b. (MR 18.08.2004) The same examination: sagittal
contrast-enhanced T1-weighted image. Complete regression of the
lesion within the optic chiasm
Rycina 2b. To samo badanie — obraz T1-zależny w projekcji
strzałkowej po wzmocnieniu kontrastowym; całkowita regresja
nacieku skrzyżowania wzrokowego
Figure 2a. (MR 18.08.2004) Coronal contrast-enhanced T1-
-weighted MR image shows no pathological changes within the
suprasellar region. Optic chiasm is still normal; regression of the
lesion
Rycina 2a. Obraz T1-zależny w projekcji czołowej wykonany po
dożylnym podaniu kontrastu nie wykazuje zmian w okolicy
nadsiodłowej; skrzyżowanie wzrokowe jest prawidłowe; regresja
nacieku
Table I
Results of hormonal and osmolal analyses in the patient with
optic chiasm lymphoma infiltration before the hormonal
replacement
Tabela I
Wyniki badań hormonalnych i osmolalności u chorego
pacjenta z chłoniakiem naciekającym skrzyżowanie
wzrokowe przed wdrożeniem substytucji hormonalnej
Test Value Normal range
TSH [mIU/l] 0.265 (0.4–4)
fT4 [pmol/l] 5.57 (9–20)
ACTH [pg/ml] 5.0 (0–46)
Cortisol 08.00 [ng/ml] 11.6 (94–260)
Cortisol 20.00 [ng/ml] 12.8 (18–127)
LH [mU/ml] 1.53 (2–10)
FSH [mU/ml] 4.58 (2–15)
Testosterone [ng/ml] < 0.5 (1.8–7.5)
GH [ng/ml] 0.39 (< 4)
Prolactin [ng/ml] 45.3 (3–15)
Urine osmolality [mOsm/kg] 211 (300–400)
Serum osmolality [mOsm/kg] 316 (284–293)
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hypothalamic infiltration. The visual disturbances were
parallel to pathological changes in the optic chiasm
region described on scans, but the hormonal deficiencies
remained persistent during the follow-up time owing
to hypothalamus failure.
The follow-up of the lesion images is our case is very
interesting. The infiltration disappeared in the course
of the chemotherapy, but recurred, then changed its
appearance (from hyperdense with contrast enhance-
ment into hypodense without contrast enhancement)
and finally disappeared again. This patient survived for
over two years after hypothalamochiasmatic infiltration
was documented (July 2003–September 2005) and for
four years after lymphoma had been diagnosed (March
2001), which is quite unusual for patients with CNS lym-
phoma. Hormonal disturbances accompanying the su-
prasellar region infiltration are very important from the
practical point of view.
Discussion
Pituitary lesions secondary to other disorders are not
common. They may reveal tumours metastatic to the
pituitary gland, pituitary infiltration, or lymphoma.
Neoplasms from almost every origin have been repor-
ted to metastasise to the pituitary. These tumours re-
flect most commonly breast and lung cancers in wo-
men and men respectively. The remaining metastases
are of gastrointestinal, prostate, kidney, skin, thyroid
and other origin. All pituitary metastases are less than
1% of tumorous pituitary lesions subjected to pituitary
tumour surgery. They can diminish together with suc-
cessful chemotherapy of the primary focus. Pituitary
involvement can exert both mass effect and induce hor-
monal disturbances. The former is reflected in visual
field defects and vision loss, while the latter leads to
pituitary deficiencies with concomitant hyperprolacti-
naemia and diabetes insipidus when hypothalamic
function is disturbed [11–13].
In a review of the location of metastasis to the pitu-
itary gland in 201 cases an involvement of the posterior
lobe either alone or in combination with the anterior
lobe was found in 84.6%, whereas only the anterior lobe
was affected in 15.4% [13]. The most common symp-
tom seems to be diabetes insipidus, reflecting a predo-
minance of metastasis to the posterior lobe [12]. In
a review of 40 symptomatic cases diabetes insipidus was
noted in 70%, whereas only 15% had one or more ante-
rior pituitary hormone deficiencies [13]. However, re-
cent studies show a higher rate of anterior pituitary in-
volvement (23.6%) [12]. Ntyonga-Pono et al., reviewing
72 patients from the literature, found that only 10% of
patients survived more than one year after diagnosis,
the longest survival being three years. Patients with
a single pituitary metastasis may have a better outcome
(2.5 years) [14].
A large series reported of carcinoma metastatic to
the pituitary gland does not mention lymphoma, altho-
ugh it does report 4 of 220 (1.9%) cases of leukaemia
metastatic to the pituitary [13]. A haematological origin
of a primary tumour metastatic to the pituitary in
380 cases included: leukaemia — 5 cases (1.3%), multi-
ple myeloma — 3 (0.8%), lymphoma — 2 (0.5%) and
lymphosarcoma — 1 (0.3%) [12]. On the other hand,
lymphomas or other haematological malignancies in-
volving the CNS were found in 8 out of 119 patients
(6.7%) aged 75 and older undergoing neurosurgical in-
terventions [15]. The number of CNS lymphomas has
increased recently owing to the increasing number of
patients suffering from AIDS and immunosuppression
[9]. In an autopsy series carried out on 165 patients who
had died because of haematological malignancies
38 cases (23%) of pituitary lymphoma were found [16].
Lymphomas of the pituitary and suprasellar region
can be of primary origin or reflect the whole-body dis-
semination of the general disease [6, 17]. Primary pitu-
itary lymphomas are not frequent; they present with
mass effects, transient or permanent endocrinopathies,
headache, cranial nerve abnormalities and also fever
[18]. Several cases of primary pituitary lymphoma have
been reported to date. They are sometimes diagnosed
after trans-sphenoidal biopsy, neurosurgery or postmor-
tem [2, 19–21] and the majority of them represent B-cell
non-Hodgkin’s lymphoma [17, 18]. For example, a dif-
fuse pleomorphic B-cell lymphoma with diabetes insi-
pidus was diagnosed primarily in the pterygopalatine
fossa on both sides with infiltration of the clivus, caver-
nous sinus and neurohypophysis. Diabetes insipidus
disappeared following chemotherapy [22]. Non-Hodg-
kin’s lymphoma can involve both hypophysis, with
symptoms of anterior pituitary failure, and the adre-
nals [23]. Several cases of active acromegaly associated
with intrasellar lymphoma and also CNS lymphoma in
the course of GH therapy have been described, sugge-
sting the role of IGF-1 in the tumorigenesis [24, 25].
Other pituitary lesions include infiltrative ones, and
these can involve lymphocytic hypophysitis, sarcoido-
sis, tuberculosis, histiocytosis X and pituitary abscesses.
These lesions require specific and targeted treatment
[12, 26, 27].
Optic nerve and chiasm involvement by the lym-
phoma is unusual, and generally occurs late in the co-
urse of the disease. There are a few cases reported in
the literature of both non-Hodgkin’s and Hodgkin’s lym-
phoma in this location, often with visual loss. Other symp-
toms could be headaches or decreased hearing [7, 8, 28].
These lesions can develop without any endocrinologi-
cal disturbances. The proper diagnosis was usually
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given following mass surgery, biopsy or postmortem
evaluation. Some of these lesions respond well to ste-
roid therapy [7, 29, 30].
Primary hypothalamic lymphomas are considered
quite exceptional. There are reports of lesions of either
the third ventricle region and adjacent hypothalamic
area, with progressive visual deterioration, diabetes in-
sipidus and mental confusion [10], or the hypothala-
mic/chiasmal mass with visual loss, hypopituitarism and
the stiff-man syndrome [31]. Our case is very similar to
these, sharing the localisation and clinical picture of both
the above-mentioned reports. In contrast, however, it
does not represent primary hypothalamic lymphoma
but the hypothalamo/chiasmatic spread of the diffuse
disease.
Hyperprolactinaemia has been reported to accom-
pany metastases to the posterior pituitary and infundi-
bulum as a result of stalk compression, and the degree
of hyperprolactinaemia may be helpful in distinguishing
the above-mentioned disturbances from a true prolac-
tinoma [12]. On the other hand, hyperprolactinaemia
has been observed in patients with advanced multiple
myeloma as an atypical marker of the disease [32].
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